Traversal raises $120M Series B at $1B valuation to scale AI site reliability tools
<cite index="14-1">Unite.AI reports</cite> that Traversal, a New York company selling AI agents for site reliability engineering, <cite index="1-2">closed a $120 million Series B at a $1 billion valuation</cite>. <cite index="1-3">Kleiner Perkins, Redpoint Ventures and Khosla Ventures co-led the round, with Sequoia Capital, Battery Ventures and Amex Ventures participating.</cite> <cite index="14-4">Earlier backers Kleiner Perkins and Sequoia also increased their investments.</cite>
Traversal began with incident root-cause analysis, <cite index="1-5">drawing on three co-founders' academic research in causal machine learning and reinforcement learning.</cite> <cite index="1-6">The company says monthly investigations grew from 513 to nearly 73,000 during 2026.</cite> <cite index="1-7">In a separate funding release it reports ninefold year-to-date growth in annual recurring revenue, more than 150,000 customer investigations last quarter and support for over 4,000 engineers.</cite> <cite index="5-6">Its technology centers on a Production World Model and a Causal Search Engine designed to track dependencies and potential root causes.</cite>
The new money will expand research, engineering and go-to-market teams while the platform moves deeper into the software development lifecycle. <cite index="14-5">Total funding now stands at $173 million, following the $48 million Traversal announced when it emerged from stealth in June 2025.</cite> <cite index="10-6">Amex Ventures had made a strategic investment earlier, and American Express has also engaged Traversal's technology.</cite>
Why it matters
For founders, the round suggests that a $1 billion valuation is still reachable for software that runs inside engineering operations rather than in customer-facing chat products. Traversal's investor group pairs growth-stage firms with the venture arm of a large payments company, which points to demand from both finance and enterprise buyers. Founders building agents for production environments should read that as a signal about where budgets are going.
Teams selling agents into production should expect buyers to ask for reliability evidence, and investors will likely price that proof into their terms. <cite index="2-9">Those figures are company-reported.</cite> A buyer evaluating a similar product will want independent trials and measured outcomes, not only vendor metrics. Founders who can show shorter incident times in their customers' environments will have a stronger case in the next round.
